On August 10, 2026, at 2:00 p.m., Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol proceeded to the Convention Hall, Chulabhorn Research Institute Convention Center, to graciously grant an audience to representatives from various agencies and the general public to present donations and join Her Royal Highness in contributing to the “Hataitip Fund” under the Chulabhorn Foundation. On this occasion, Assoc. Prof. Dr. Chusak Limsakul, Vice Chairperson of the Hataitip Fund Executive Committee, presented a report on the fund’s operations. The fund has been driven by Her Royal Highness’s determination to enhance the security and safety of the public and frontline personnel defending the nation’s sovereignty. Since its official launch, the fund has continuously received support from people of all walks of life, with total donations reaching 252,840,253.28 baht (as of August 9, 2026). Subsequently, Assoc. Prof. Dr. Chusak requested permission for General Ukrit Boontanon, Commander in Chief of the Royal Thai Armed Forces, and General Pana Claewplodtook, Commander in Chief of the Royal Thai Army, to present their reports on the progress of border fence construction and various protective infrastructures in risk areas along the Thai-Cambodian border, managed by the Royal Thai Armed Forces Headquarters and the Royal Thai Army, respectively. Following this, Her Royal Highness viewed a video presentation on...

On June 19, 2026 at 1.50 p.m., at the Agrarajakumari Building, Chulabhorn Hospital, Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana graciously granted an audience to Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D., Chairman of Mahidol University Council, and delegation, to humbly present to Her Royal Highness an Honorary Doctorate of Philosophy in Chemistry for the academic year 2024. Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana, in Her capacity as President of the Chulabhorn Research Institute (CRI), established the CRI with the aim of applying science and technology to elevate people’s quality of life, and developing the nation’s medical sciences and public health, especially in addressing the health issues involving cancer as people still have difficulty accessing effective drugs. Her Royal Highness recognizes the expediency and necessity for Thailand to develop competency in drug self-reliance on par with international standards and the ability to effectively apply drugs for patient treatment. Under Her Royal Initiative, a Pharmaceutical Manufacturing Facility was established under the Chulabhorn Royal Academy. It is the first facility in Thailand to produce drugs for cancer treatment. It is also accredited to the international GMP PIC/S standard, which will reduce the costs of importing drugs and increase opportunities for people to have equal and sustainable access to quality drugs for cancer treatment across the board....

Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana has tirelessly performed Royal Duties in the fields of medicine and public health, reflecting Her compassion for the Thai people. Her Royal Highness recognizes that the people’s good health is a major factor contributing to quality livelihood and plays a pivotal role in national development, progress, and prosperity. As Honorary President of the Princess Mother’s Medical Volunteer Foundation (PMMV) since 2009, Her Royal Highness has paid Royal Visits and provided assistance for the treatment of the sick in remote areas across the country through the PMMV’s operations up to the present. On this important mission, Her Royal Highness paid a Royal Visit to the PMMV in the North from April 20-25, 2026 at Thungkaowwittayakom School, Lampang Province, Pasang Industrial and Community Education College, Lamphun Province, and Chomthong School, Chiang Mai Province to observe operations and boost the morale of officials, as well as local people who came for treatment services. All expressed their gratitude in recognition of Her Royal Highness’s immeasurable benevolence. In particular, Her compassion extends to needy patients, suffering from severe diseases and requiring continuous and timely treatment, such as congenital heart disease, primary peritoneal cancer, cleft lip and cleft palate, cerebral palsy, and scoliosis. Her Royal Highness worked with the medical team to make diagnoses and kindly...

On February 18, 2026 at 1.38 p.m., on the 6th Floor, Krom Phra Srisavangavadhana Building, Chulabhorn Hospital, Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana graciously gave the opportunity to Khunying Charatsri Teepirach, Vice President for Administration and Director, Office of the President, Chulabhorn Research Institute, to bring donors to have an audience with Her Royal Highness, and humbly make contributions to the “Hataitip Fund” under the Chulabhorn Foundation. On this occasion, representatives from various sectors made contributions to the Fund and received Royally granted mementos from Her Royal Highness. The “Hataitip Fund” is a Fund under the Royal Initiative and through the benevolence of Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana, Chair of the Fund’s Executive Committee. Its objective is to support the key missions of the government, the private sector, and the public in preventing and alleviating suffering caused by unrest, conflicts, natural disasters, or situations posing threats to people’s lives and property, as well as national security, especially the current situations along the Thai-Cambodian border. Her Royal Highness bestowed Her Royal Policy to provide budgetary support for various construction projects along the border under the operations of the Royal Thai Armed Forces and the Royal Thai Army. The two agencies humbly received Her Royal Highness’s Royal Policy for implementation. These operations include...

Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol is filled with great compassion and deeply concerned with the well-being of the Thai people. As the country faces tensions along the Thai-Cambodian border – affecting the safety, quality of life, and well-being of local residents, especially health issues of the sick and disadvantaged, as well as displaced people who lack access to normal medical and public health services as in normal situations – Her Royal Highness directed the Princess Mother’s Medical Volunteer Foundation (PMMV) to provide medical check-ups and treatment for the displaced people from the current situation in the three lower northeast provinces of Si Sa Ket, Surin, and Buri Ram. Her Royal Highness also bestowed Royally-Granted survival packs to initially alleviate the suffering of the affected people. The mission took place from August 29-31, 2025. Upon arrival in each area to perform Her Royal Duties, Her Royal Highness visited local people and granted audiences to patients in need – particularly those with serious chronic diseases requiring continuous care – so they could receive timely Royal Assistance. These patients included individuals suffering from conditions such as breast cancer, lymphoma, brain cancer, ischemic stroke, scleroderma, congenital heart disease, and biliary atresia. Her Royal Highness graciously took these patients under Her patronage and arranged for their transfer to the Chulabhorn Hospital or...

Professor Dr. Her Royal Highness Princess Chulabhorn MahidolPresides over the Opening Ceremony of the Center for Biologics Research and Development (CBRD) Building,Chulabhorn Research Institute (CRI)at the CBRD Building, CRI, Lak Si District, Bangkok, on Friday, August 1, 2025 With Her ability and vision to address people’s health issues, Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulabhorn Research Institute (CRI), recognizes the urgency for Thailand to build capability in drug development to support public health emergencies, including epidemics, and medicine shortage crises, with a major target of enabling all the Thai people to have access to efficient and affordable medicines. Concerned with the issues, Her Royal Highness initiated and laid the foundation to develop and produce standard biologics, in parallel with personnel development with advanced knowledge and expertise, under the Center for Biologics Research and Development (CBRD), CRI. The CBRD is readily equipped with basic infrastructure, technology, and operational system capable of supporting the comprehensive process of biologics development. On August 1, 2025 at 3.52 p.m., the President of the CRI graciously presided over the opening ceremony of the CBRD Building, CRI, Lak Si District, Bangkok. The ceremony was attended by executives of the Ministry of Public Health and the CRI who collectively paid their respects to Her Royal Highness. On this occasion, Her Royal Highness granted...

Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol Presides over the Opening Ceremony of the Academic Conference Held in Her Honor on the Topic “Frontiers in Biologics Development: Towards a Brighter Future for Thailand” at the Chulabhorn Research Institute Conference Center, Bangkok On August 1, 2025 at 09.00 a.m., Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulabhorn Research Institute (CRI), presided over the opening ceremony of the academic conference held in Her Honor on the topic “Frontiers in Biologics Development: Towards a Brighter Future for Thailand” at the Chulabhorn Research Institute Conference Center. The CRI organized the conference to honor Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol who successfully conducted research, development and production of the “trastuzumab” biosimilar for the treatment of cancer patients. The biosimilar was granted a drug registration license by the Food and Drug Administration, Ministry of Public Health, under the name “HERDARA” which was graciously bestowed by Her Royal Highness. This success constitutes a major step in fostering Thailand’s potential to develop drugs without depending on purchases or technology transfer from abroad. An excerpt of Her Royal Highness’ s address at the opening ceremony is as follows “…Biologics are considered highly safe drugs. They contribute to the hope of treating various present and future diseases …His Majesty King Bhumibol Adulyadej the...

Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol has achieved a groundbreaking milestone in the research, development, and production of a “trastuzumab” biosimilar used in cancer treatment. From upstream to downstream processes, this innovation was accomplished entirely by Thai researchers without relying on foreign technology transfer. It marks Thailand’s first biosimilar developed domestically for the benefit of the Thai people. The drug officially named “HERDARA” was granted registration license from the Food and Drug Administration, Ministry of Public Health, on May 20, 2025. It is generally known that cancer remains the number one cause of death in Thailand and tends to increase while the medicines to treat the disease are expensive as they have to be imported. With Her vision to address health issues of the Thai people, Her Royal Highness has tirelessly committed to Thailand’s medical and public health development. Recognizing people’s difficulties in having access to very expensive biologics efficient in treating diseases, especially cancer, Her Royal Highness has taken the initiative and laid the foundation to develop biologics domestically under the Project “Center for Biologics Research and Development”. Her Royal Highness directed researchers at the Chulabhorn Research Institute (CRI) to brainstorm for the invention and development of biosimilars that meet international standards and ensure therapeutic efficacy. These efforts not only enhance national self-reliance in biologic medicines but...

Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulabhorn Research Institute (CRI), has unwaveringly dedicated Herself to improving the quality of life and livelihood of the Thai people through campaigns promoting good health and safety of the people from serious diseases, especially rabies, a life-threatening zoonotic disease with no cure. Once the disease shows its symptoms, it will be fatal to all infected individuals. Driven by this strong commitment, the President of the CRI has relentlessly and concretely addressed the issues of rabies under HRH Princess Chulabhorn’s project on “Disease-free Animals, Safe Humans from Rabies”. Since 2016, Her Royal Highness has closely followed the situations of the spread of rabies in the country. Her Royal Highness is aware that more cases of the spread of rabies are currently found in the east, resulting in people’s death and widespread outbreaks among animals. Moreover, most local people still lack proper knowledge and understanding of the dangers posed by rabies. Concerned with these challenges, Her Royal Highness directed the Chulabhorn Veterinary Volunteer Unit to conduct activities in Sakaeo, Prachinburi, and Chachoengsao Provinces from April 4-6, 2025. Under Her Royal Highness’s leadership, veterinarians from the Chulabhorn Veterinary Volunteer Unit collaborated with their counterparts from the Faculty of Veterinary Medicine, Kasetsart University, local Provincial Livestock Offices, District 2 Livestock Office, and other...

Royal Visit to the Federal Republic of Germany From January 17-27, 2025 to Strengthen Cooperation with World-Leading Research Institute on Research, Academic Works, and Modern Innovation, Elevating Sustainable Quality of Life Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulabhorn Research Institute (CRI), has tirelessly committed Herself to the development and creation of knowledge through study, research, academic work, and modern innovation. This is achieved through quality study and research processes on par with international standards and a consistent focus on promoting the health and quality of life of the Thai people. In January 2025, Her Royal Highness made a Royal Visit to the German Cancer Research Center (DKFZ) in Heidelberg, Federal Republic of Germany. The DKFZ has had a long-standing collaboration with the CRI through Her Royal Highness’s ongoing research, academic work, and visits to observe cutting-edge research activities in parallel with efficient cancer treatment. Prof. Dr. Michael Baumann, Chair of the Management Board and Chair of the Scientific Director of the German Cancer Research Center, along with executives, were in attendance to welcome Her Royal Highness. On this occasion, Her Royal Highness delivered an address on the relationship and cooperation between the two Institutes in their efforts to produce personnel in research, innovation, and medicine with expertise at the international level. “It is my great...

Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol Presides over the Closing Ceremony of the 9th Princess Chulabhorn International Science Congress On December 18, 2024 at 3.55 p.m., Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulabhorn Research Institute, presided over the closing ceremony of the 9thPrincess Chulabhorn International Science Congress under the theme “The Challenges of One Health: The Roles of Biosciences and Chemistry”. The Congress was held to honor His Majesty King Maha Vajiralongkorn Phra Vajiraklaochaoyuhua on the auspicious occasion of His Majesty’s 72nd Birthday Anniversary on July 28, 2024. This important International Congress focused on the key roles of biosciences and chemistry and the solutions to overcome the challenges of “One Health” based on the concept of the World Health Organization (WHO). This concept and the methods to address health issues are new, integrating human, animal health and the environment, leading to the comprehensive promotion of good health and enabling all creatures on earth to live together in safety and security. The event was held from December 15-18, 2024 at Shangri-La Hotel Bangkok. On this occasion, Her Royal Highness graciously granted the Princess Chulabhorn Gold Medal Award of Appreciation to six recipients as follows: 1. Dr. Norbert Frank, Federal Republic of Germany An academic who has been a long-standing benefactor of and collaborator with...

On December 17, 2024 at 12.49 p.m., Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulaborn Research Institute (CRI), graciously delivered a special lecture titled “Protecting Animal and Human Lives from Rabies Project: One Health Approach for Rabies Control and Elimination in Thailand” at the 9thPrincess Chulabhorn International Science Congress. The event was held in the Grand Ballroom, Shangri-La Hotel Bangkok. The main points of Her Royal Highness’s lecture were greatly beneficial in fostering cooperation to address the rabies-related issues in Thailand and around the world. Rabies is a serious zoonotic disease, caused by the rabies virus in all species of mammals and currently has no cure. The disease is fatal if infected individuals are not treated promptly. The President of the CRI is deeply concerned about rabies as a significant public health issue in Thailand. HRH Princess Chulabhorn’s project on “Disease-free Animals, Safe Humans from Rabies” has been in operation since 2016 under the “One Health” concept. It aims to integrate cooperation among relevant agencies through the eight core strategies, involving animal health, human health, disease surveillance, prevention, and control of rabies, legal frameworks, public awareness campaigns and community engagement, aiming to reach the target of the World Health Organization to eradicate rabies in Thailand and around the world by 2030. It also emphasizes disease prevention...